Balanced news tone
News Sentiment
HROW sentiment intelligence
Harrow Health Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
77/100 classification confidence.
directly relevant articles
high-authority source matches
-0.6% over one week, +12.9% over four weeks, trend inactive, and materially above fair value.
Harrow Inc (HROW) Shares Surge 3.9% -- What GF Score of 81 Tells Investors
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Can Harrow’s (HROW) VERKAZIA Relaunch Redefine Its Niche Ophthalmic Strategy?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jun 2026 07:00
- Source
- Market source
HROW Stock Rises on Relaunch of Ophthalmology Drug Verkazia in the US
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jun 2026 07:00
- Source
- Zacks Investment Research
Harrow Re-Launches VERKAZIA® (cyclosporine ophthalmic emulsion) 0.1% for Vernal Keratoconjunctivitis, Addressing Significant Unmet Need in Pediatric Eyecare
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 11:00
- Source
- GlobeNewswire
What Does Cantor Fitzgerald Think About Harrow (HROW) After Cutting Its Price Target?
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 04 Jun 2026 21:43
- Source
- Insider Monkey
Harrow to Present at William Blair’s 46th Annual Growth Stock Conference
- Tone
- Positive 58/100
- Event
- Market update
- Published
- 27 May 2026 11:00
- Source
- GlobeNewswire
Why B.Riley Reduced Harrow, Inc. (HROW) Price Target Despite Long-Term Optimism
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 20 May 2026 07:00
- Source
- Market source
Why Harrow (HROW) Narrative Is Shifting As Analysts Recut Targets Yet Stay Positive
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 15 May 2026 07:00
- Source
- Market source
Opaleye entities report 7.61% stake in Harrow (NASDAQ: HROW)
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 11 May 2026 07:00
- Source
- Stock Titan
Harrow (HROW) Reports Q1 Loss, Lags Revenue Estimates
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
Harrow Inc. (HROW) stock falls on Q1 2026 Earnings
- Tone
- Negative 22/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Quiver Quantitative
Is Harrow (HROW) Pricing Reflect Its 65.5% One Year Surge And DCF Outlook
- Tone
- Positive 66/100
- Event
- Guidance
- Published
- 09 May 2026 07:00
- Source
- Market source
Harrow Inc (NASDAQ:HROW) Screens as a Strong Growth Stock with a Bullish Technical Setup
- Tone
- Positive 95/100
- Event
- Market update
- Published
- 08 May 2026 07:00
- Source
- ChartMill
Analysts Estimate Harrow (HROW) to Report a Decline in Earnings: What to Look Out for
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 04 May 2026 07:00
- Source
- Market source
Is Harrow, Inc. (HROW) A Good Stock To Buy Now?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 30 Apr 2026 07:00
- Source
- Market source
Harrow shifts U.S. eye drug distribution to LogiCare3PL in 4 weeks
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Apr 2026 07:00
- Source
- Stock Titan
A Look Back at Health Insurance Providers Stocks’ Q4 Earnings: Alignment Healthcare (NASDAQ:ALHC) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 03 Apr 2026 07:00
- Source
- Market source
HARROW INC (NASDAQ:HROW): A GARP Stock with Strong Growth at a Reasonable Price
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 26 Mar 2026 07:00
- Source
- ChartMill
Harrow (HROW) Misses Q4 Earnings Estimates
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 02 Mar 2026 08:00
- Source
- Market source
Harrow Inc. (HROW) Stock Falls on Q4 2025 Earnings
- Tone
- Negative 22/100
- Event
- Earnings
- Published
- 02 Mar 2026 08:00
- Source
- Quiver Quantitative
Harrow Announces Availability of Fortisite™ Formulations for In-Office Use
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jan 2023 08:00
- Source
- Business Wire
Harrow Secures Capital to Close Recently Announced Acquisition
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 16 Dec 2022 08:00
- Source
- Business Wire
Harrow Health Announces Second Quarter 2022 Financial Results
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 09 Aug 2022 07:00
- Source
- Business Wire
Harrow (HROW) Stock Price, News & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Feb 2019 02:56
- Source
- MarketBeat